News

J&J wins appeals court ruling against Teva and Viatris in patent dispute over neuro drug
J&J(JNJ) wins U.S. appeals court case protecting its Invega Sustenna patent from generic rivals Viatris (VTRS) & Teva (TEVA).
J&J defeats generic drugmakers in US appeal over schizophrenia treatment
Johnson & Johnson convinced a U.S. appeals court on Tuesday to reject a bid from generic drugmakers Teva and Viatris to ...